Goepper Burkhardt’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$364K Buy
396
+32
+9% +$32.4K 0.12% 73
2025
Q4
$391K Hold
364
0.13% 71
2025
Q3
$278K Hold
364
0.09% 83
2025
Q2
$284K Buy
364
+27
+8% +$21K 0.1% 79
2025
Q1
$278K Buy
337
+23
+7% +$19.1K 0.11% 80
2024
Q4
$242K Sell
314
-12
-4% -$9.94K 0.1% 75
2024
Q3
$289K Hold
326
0.12% 66
2024
Q2
$295K Sell
326
-2
-0.6% -$1.6K 0.13% 65
2024
Q1
$249K Buy
328
+16
+5% +$11.4K 0.12% 72
2023
Q4
$231K Buy
+312
New +$182K 0.11% 72

Other funds holding LLY

Goepper Burkhardt's LLY Position: Q1 2026 in Review

Goepper Burkhardt increased its Eli Lilly (LLY) stake by 8.8% in Q1 2026, buying an estimated $32.4K and bringing the position to 396 shares worth $364K. The position accounts for 0.12% of the portfolio, ranked #73.

Goepper Burkhardt first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $391K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Goepper Burkhardt held 396 shares of Eli Lilly worth $364K as of Q1 2026.
  • Goepper Burkhardt bought 32 Eli Lilly shares in Q1 2026, an estimated $32.4K.
  • Eli Lilly made up 0.12% of Goepper Burkhardt's portfolio in Q1 2026, its #73 holding.
  • Goepper Burkhardt first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Goepper Burkhardt's Eli Lilly position peaked at $391K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Goepper Burkhardt's 13F filing for Q1 2026, filed 13 May 2026.